Wednesday, 28 June 2017

Biologics News

  • Austrianova starts cell bank for cancer therapy

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2013

    Singapore: Austrianova Singapore has established a research cell bank, the first step towards late-phase clinical trials in patients with advanced inoperable pancreatic cancer, as well as a...Read more

  • Genzyme to invest $80 mn to boost Fabrazyme production

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 17 Oct, 2013

    Singapore: Genzyme, a Sanofi company, plans to invest USD80 million to build a new downstream processing facility for Fabrazyme (agalsidase beta) to expand purification capacity to support ...Read more

  • Australian academy of science gets new council members

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 21 Nov, 2012

    Singapore: Internationally-recognized experts in computing and atmospheric physics, developmental biology, organometallic chemistry and evolutionary genetics have been elected to join the A...Read more

  • China marches ahead with regulatory approvals

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2012

    After five years of amendments and two rounds of public consultations, the State Food and Drug Administration (SFDA) issued Good Manufacturing Practice for Drugs that came into effect on Ma...Read more

  • Ranbaxy to market infliximab biosimilar

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 09 Jan, 2014

    Singapore: Switzerland based EPIRUS, a wholly-owned subsidiary of Boston-based EPIRUS Biopharmaceuticals, and Ranbaxy Laboratories, a division of Daiichi Sankyo Company, Tokyo, have signed ...Read more

  • David Johnston to lead PPD's lab services

    Biologics |  Influencers | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2013

    Singapore: Pharmaceutical Product Development (PPD) has appointed Dr David Johnston as executive vice president of global laboratory services.Dr Johnston is to direct PPD's laboratory servi...Read more

  • Agilent, Korea institute to launch neurometabolomics center

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 28 Oct, 2013

    Singapore: Agilent Technologies and Korea-based Daegu Gyeongbuk Institute of Science and Technology (DGIST) have collaborated to launch DGIST's new Neurometabolomics Excellence Research Cen...Read more

  • Shire biologics facility gets FDA clearance

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 18 Feb, 2014

    Singapore: Shire, global specialty biopharmaceutical company, has recieved US FDA approval for production of VPRIV drug substance (velaglucerase alfa for injection) in Shire's manufacturing...Read more

  • MedImmune, UCSF enter 3-year R&D deal

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 18 Feb, 2014

    Singapore: MedImmune, the global biologics R&D arm of AstraZeneca, has entered into a three-year collaboration with the Clinical and Translational Science Institute (CTSI) at the Univer...Read more

  • D A Prasanna is ACRO India's new Chairman

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2014

    Singapore: On January 10 2014, members of Association of Contract Research Organizations (ACRO INDIA) met and Mr D A Prasanna was elected unanimously as the Chairman of the Association. He ...Read more

  • India announces new biosimilar regulatory guidelines

    Biologics |  Regulatory | By Narayanan Suresh | 0 Comment | 19 Jun, 2012

    Boston: India has announced the much-awaited new and simple regulatory guidelines for similar biologics which have been approved and marketed in USA or Europe for more than four years. Th...Read more

  • Aussie's CardioCel gets US approval

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2014

    Singapore: Australia based Admedus has received FDA clearance to market CardioCel in the US. CardioCel is the group's lead regenerative tissue product to repair and treat a range of cardio...Read more

  • Asia biologics manufacturers face the 'quality challenge'

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2012

    Biologics manufacturers in Asia have to be more vigilant and give higher priority to product safety and product efficacy. Even though countries like India and China can lower manufacturing ...Read more

  • Boehringer develops disposable manufacturing technology

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2012

    Singapore: Boehringer Ingelheim has developed and implemented a flexible set-up and operational approach for disposable technologies within its global biopharmaceutical development and manu...Read more

  • California closer to get biosimilars bill

    Biologics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2013

    Singapore: The US State of California's biosimilar Senate Bill 598, which is a pharmacy substitution law to allow greater patient access to more affordable FDA-approved biologic medicines,...Read more

  • Can Asian biologics manufacturers live up to global regulatory standards?

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2012

    When it comes to contract biologics manufacturing, despite the increasing opportunities, there is a concern regarding the Asian countries' ability to abide by the regulatory system that com...Read more

  • Sigma-Aldrich to launch Austrianova's encapsulation technology

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2014

    Singapore: Sigma-Aldrich, bioscience and technology company, is set to commercialize a kit for hand-driven, self-encapsulation of cells, designed by the Singapore based biotech company Aust...Read more

  • Old drug gives hope for new treatment in autism

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013

    Singapore: Autism results from abnormal cell communication. Testing a new theory, researchers at the University of California, San Diego School of Medicine, have used a newly discovered fun...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls